Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 2
1997 2
1998 2
1999 2
2001 1
2002 2
2004 3
2005 1
2006 2
2007 1
2008 3
2009 1
2010 2
2011 2
2012 2
2013 1
2015 3
2017 1
2018 3
2019 2
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME Investigators. Zinman B, et al. N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17. N Engl J Med. 2015. PMID: 26378978 Free article. Clinical Trial.
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. Green JB, et al. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. N Engl J Med. 2015. PMID: 26052984 Free article. Clinical Trial.
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators. Hernandez AF, et al. Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2. Lancet. 2018. PMID: 30291013 Clinical Trial.
Proton-beam therapy for tumors of the CNS.
Gridley DS, Grover RS, Loredo LN, Wroe AJ, Slater JD. Gridley DS, et al. Among authors: loredo ln. Expert Rev Neurother. 2010 Feb;10(2):319-30. doi: 10.1586/ern.09.150. Expert Rev Neurother. 2010. PMID: 20136386 Review.
Conformal proton therapy for prostate carcinoma.
Slater JD, Yonemoto LT, Rossi CJ Jr, Reyes-Molyneux NJ, Bush DA, Antoine JE, Loredo LN, Schulte RW, Teichman SL, Slater JM. Slater JD, et al. Among authors: loredo ln. Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):299-304. doi: 10.1016/s0360-3016(98)00225-9. Int J Radiat Oncol Biol Phys. 1998. PMID: 9788407 Clinical Trial.
Biosynthetic approach for functional protein microarrays.
Stamos B, Loredo L, Chand S, Phan TV, Zhang Y, Mohapatra S, Rajeshwar K, Perera R. Stamos B, et al. Among authors: loredo l. Anal Biochem. 2012 May 15;424(2):114-23. doi: 10.1016/j.ab.2012.02.019. Epub 2012 Feb 25. Anal Biochem. 2012. PMID: 22370272
Multiple sensory illusions are evoked during the course of proton therapy.
Narici L, Titova E, Obenaus A, Wroe A, Loredo L, Schulte R, Slater JD, Nelson GA. Narici L, et al. Among authors: loredo l. Life Sci Space Res (Amst). 2020 Aug;26:140-148. doi: 10.1016/j.lssr.2020.04.006. Epub 2020 May 22. Life Sci Space Res (Amst). 2020. PMID: 32718680
38 results